MedTrace Logo

The Efficacy of Integrated Behavioral Therapy for Selective Mutism

NCT04585048 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-16

No results posted yet for this study

Summary

This study examines the efficacy of the Integrated Behavioral Therapy for Selective Mutism protocol (Bergman et al., 2013). Participants are 60 children, aged 4-8 years, diagnosed with Selective Mutism (SM). The level of SM symptoms is assessed during first arrival to the SM unit of Schneider Children's Medical Center of Israel (Intake), at the first treatment session, at sessions 12, and at the end of treatment.

A secondary aim of this study is to assess the contribution of parent's characteristics (anxiety and depression levels, parenting style) to the childrens' SM symptoms level and to treatment achievements.

Conditions

  • Selective Mutism

Interventions

BEHAVIORAL

Integrated Behavioral Therapy for Selective Mutism

Cognitive Behavioral treatment including 24 weekly sessions

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Maayan shorer, PhD · Schneider Children's Medical Center, Israel

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-14
Primary Completion
2021-05-01
Completion
2023-03-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04585048 on ClinicalTrials.gov